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Abstract
Background Extended full thickness skin defects still
represent a considerable therapeutic challenge as ideal
strategies for definitive autologous coverage are still not
available. Tissue engineering of whole skin represents an
equally attractive and ambitious novel approach. We have
recently shown that laboratory-grown human skin ana-
logues with near normal skin anatomy can be successfully
transplanted on immuno-incompetent rats. The goal of the
present study was to engineer autologous porcine skin
grafts for transplantation in a large animal model (pig
study = intended preclinical study).
Materials and methods Skin biopsies were taken from the
pig’s abdomen. Epidermal keratinocytes and dermal
fibroblasts were isolated and then expanded on culture
dishes. Subsequently, highly concentrated collagen hydro-
gels and collagen/fibrin hydrogels respectively, both con-
taining dermal fibroblasts, were prepared. Fibroblast
survival, proliferation, and morphology were monitored
using fluorescent labelling and laser scanning confocal
microscopy. Finally, keratinocytes were seeded onto this
dermal construct and allowed to proliferate. The resulting
in vitro generated porcine skin substitutes were analysed by
H&E staining and immunofluorescence.
Results Dermal fibroblast proliferation and survival in
pure collagen hydrogels was poor. Also, the cells were
mainly round-shaped and they did not develop 3D-net-
works. In collagen/fibrin hydrogels, dermal fibroblast
survival was significantly higher. The cells proliferated
well, were spindle-shaped, and formed 3D-networks. When
these latter dermal constructs were seeded with keratino-
cytes, a multilayered and partly stratified epidermis readily
developed.
Conclusion This study provides compelling evidence
that pig cell-derived skin analogues with near normal
skin anatomy can be engineered in vitro. These tissue-
engineered skin substitutes are needed to develop a large
animal model to establish standardized autologous trans-
plantation procedures for those studies that must be con-
ducted before ‘‘skingineering’’ can eventually be clinically
applied.
Keywords Tissue engineering  Skin culture 
Transplantation  Pig model
Introduction
Large full thickness skin defects typically result from
burns, massive avulsion injuries, septic skin necroses, or
from extended excision of scars or nevi [1–10]. The cov-
erage of such lesions still poses a very significant chal-
lenge: the functionally and cosmetically best therapeutic
option is transplanting full thickness autologous skin,
however, donor sites are limited in a prohibitive way when
there is extensive demand [11–14]. On the other end of the
therapeutical spectrum stands the almost unlimited supply
of cultured autologous epithelial autografts (CEA) (in
numerous variations) that, despite enormous basic science
E. Braziulis  T. Biedermann  F. Hartmann-Fritsch 
L. Pontiggia  S. Bo¨ttcher-Haberzeth  E. Reichmann
Department of Surgery, Tissue Biology Research Unit,
University Children’s Hospital Zurich, Zurich, Switzerland
C. Schiestl  S. Bo¨ttcher-Haberzeth  M. Meuli (&)
Department of Surgery, Pediatric Burn Center, Plastic and
Reconstructive Surgery, University Children’s Hospital Zurich,
Steinwiesstrasse 75, 8032 Zurich, Switzerland
e-mail: martin.meuli@kispi.uzh.ch
123
Pediatr Surg Int (2011) 27:241–247
DOI 10.1007/s00383-010-2777-0
and clinical research efforts, still requires 2–3 weeks of
cultivation time and still yields far from ideal results
[15–23].
Clearly, the clinical introduction of nowadays widely
used dermal regeneration templates (e.g. IntegraDRT and
Matriderm) and the development of more sophisticated
laboratory-grown skin substitutes containing keratinocytes,
fibroblasts, extracellular matrix components, growth fac-
tors, and other cytokines have pushed the frontiers further
[8, 16, 17, 24–29].
Yet, these techniques are still plagued with considerable
problems including intricate and time consuming labora-
tory processes, fragility of grafts, staged operative proce-
dures, susceptibility to infection, poor graft take, and,
finally and most importantly, not really satisfactory long
term results in terms of both functionality and cosmetic
appearance of the reconstituted skin [30–32].
We have, therefore, invested over 10 years of laboratory
research into the ambitious project of engineering an ana-
tomically near normal skin analogue. Briefly summarized,
we have managed to grow a hydrogel-based dermo-epi-
dermal construct featuring a correctly stratified epidermis,
a basement membrane, the characteristic structures of the
dermo-epidermal junction, and a close to normal, prevas-
cularized dermis [33]. These grafts, cultured from human
cells, were then successfully grafted onto immuno-incom-
petent rats [34–36].
Theoretically, this progress may be seen as the indis-
pensable evidence required before an eventual clinical
application in human patients can be envisioned. Practi-
cally, however, we are facing the problem that the above
mentioned human tissue grafts used in our rat model are
way too small and ill-configured (round grafts, 2.5 cm
diameter, covering about 4 cm2) when looking at grafts
suitable for large scale transplantation in human patients.
Ideally, such transplants should be rectangular and large
(covering 50–100 cm2).
Consequently, we have embarked on culturing skin
substitutes with near normal anatomical architecture,
mechanical properties allowing standard surgical handling,
and appropriate size matching the prerequisites for large
scale autologous transplantation in a large animal model
(=immunocompetent setting). This article describes in vitro
engineering of such grafts to be later used in pigs.
Materials and methods
In view of the envisioned animal model for large scale
autologous transplantation, we have chosen the pig
(Schweizer Edelschwein). Biopsies were taken as outlined
in detail in the companion paper published in the same
issue (Skingineering II).
Isolation and culture of keratinocytes and fibroblasts
Porcine skin samples (3 9 1 cm) were cut to 2–3 mm2
pieces and incubated for 15–18 h at 4C in 12 U/ml
dispase in HBSS containing 5 lg/ml gentamycin. The
epidermis was then separated from the dermis using
forceps. Epidermal cells were isolated by incubation in
1% trypsin, 5 mM EDTA for 3 min at 37C. After cen-
trifugation, the cell pellet was resuspended in CT57
keratinocyte medium containing 5 lg/ml gentamycin
(CELLnTEC Advanced Cell Systems AG, Bern, Switzerland),
then seeded on collagen type I-coated cell culture dishes (BD
Falcon, Basel, Switzerland). Medium was changed every
2–3 days.
The dermal tissue was digested in 2 mg/ml collagenase
for about 60 min at 37C. Isolated cells were seeded on
10 cm cell culture dishes containing fibroblast growth
medium (DMEM supplemented with 10% FCS, 4 mM
L-alanyl-L-glutamine, 1 mM sodium pyruvate, and 5 lg/ml
gentamycin) and allowed to attach overnight, before dead
cells and erythrocytes were removed by three washes in
phosphate-buffered saline (PBS). Collagenase was from
Sigma (Buchs, Switzerland), and all other compounds were
from Invitrogen (Basel, Switzerland).
Organotypic skin cultures
Organotypic cultures were prepared using a previously
established transwell system (4.2 cm2 6-well cell culture
inserts with membranes of 3.0 lm pore-size, BD Falcon,
Basel, Switzerland). A highly concentrated acidic solu-
tion of bovine collagen type I (5 mg/ml, Symatese Bio-
mate´riaux, 69630 Chaponost, France) was neutralized on
ice by dropwise addition of 0.5 M NaOH and immedi-
ately mixed with 5 9 104 human primary dermal fibro-
blasts (passage 1–2) suspended in fibroblast growth
medium. For the fibrin-containing preparations, fibrino-
gen was added to the collagen before neutralization,
thrombin was added after neutralization, and mixed
thoroughly. All components were chilled on ice during
gel preparation. The mixture was transferred into 6-well
culture inserts immediately and allowed to gel for 10 min
at room temperature before being transferred into a cell
culture incubator.
The fibroblast-containing gels were grown in fibroblast
growth medium for 3–7 days before 7.5 9 105 keratino-
cytes were seeded onto the entire surface of each gel. After
initial submersed cultivation in Rheinwald and Green
keratinocyte differentiation medium (RGM) [37] for
3–7 days, the medium level was lowered to 1.5 ml to
expose the developing epidermis to air (air–liquid inter-
face) for additional 7–10 days. Medium changes were
performed every 2–3 days.
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Fluorescein diacetate (FdA) vital cell staining
Fluorescein diacetate (FdA) staining was performed as
published and proven to be suitable for the determination
of cell viability in tissue-engineered skin [38, 39]. In short,
cell culture medium was replaced for 2 min with the equal
volume of 5 lM FdA in PBS, freshly prepared from a stock
solution of 5 mM FdA in acetone. The FdA was removed
by washing twice in PBS before fresh culture medium was
applied.
Actin and nuclear staining
Gels were fixed in 4% paraformaldehyde and permeabi-
lised in acetone/methanol (1:1) for 20 min at -20C, air
dried, and washed 39 in PBS. Then they were blocked in
PBS containing 2% BSA (Sigma) for 30 min. Cytoskeletal
actin was stained with phalloidin-TRITC in blocking buffer
for 1 h at room temperature. Slides were washed twice for
5 min in PBS. Thereafter sections were incubated for
5 min in PBS containing 1 mg/ml Hoechst 33342 (Sigma)
and then washed twice for 5 min in PBS. Finally, the
samples were mounted with Dako fluorescent mounting
solution (Dako, Baar, Switzerland).
Fluorescence microscopy
Fluorescence microscopy pictures were photographed
using a DXM1200F digital camera connected to a Nikon
Eclipse TE2000-U inverted microscope, equipped with
Hoechst 33342, FITC, and TRITC filter sets or Nikon
SMZ1500 stereo microscope with FITC filters (Nikon AG,
Egg, Switerland), (Software: Nikon ACT-1 vers. 2.70).
For confocal imaging, a Nikon C1 Laser Scanning
Microscope upgrade on the Eclipse TE2000-U was used. A
helium–neon laser with 543-nm excitation was used for
tetramethyl rhodamine iso-thiocyanate (TRITC) and 408-
nm excitation was used for Hoechst 33342. With the Plan
Apo 40 c/N.A.0.95 objective 50 optical sections were
captured. Images were processed with Imaris 6.4.0 (Bit-
plane, Zurich, Switzerland) and Photoshop 7.0 (Adobe
Systems Inc, Munich, Germany).
Results
Cell isolation
Porcine dermal fibroblasts could be isolated efficiently
from the dermis according to the protocol and media
established for the isolation of human dermal fibroblasts
[35]. Starting from a 3 9 1 cm skin biopsy, we received
approximately one million fibroblasts within 2–3 days that
could be further expanded and passaged. This efficiency as
well as proliferation rate is comparable to that of human
fibroblasts. Importantly, the morphology of porcine fibro-
blasts was typical and similar to human fibroblasts
(Fig. 1a) [40]. Most cells were viable as shown by viability
assay using FdA (Fig. 1b).
Trypsinisation of the porcine epidermis resulted in rapid
release of keratinocytes that attached within 2 h to bovine
collagen type I-coated cell culture dishes. Within 5–8 days
the keratinocytes could be expanded to six million cells in
a medium optimised for human keratinocyte precursor
enrichment. The morphology of confluent keratinocytes
resembled the typical cobblestone pattern of epithelial cells
with some interspersed large cells (Fig. 1c). By staining
with FdA we could show that the majority of cells were
vital (Fig. 1d). Therefore our procedure used for human
skin cell isolation and cultivation could be applied for
porcine cells without any changes [35].
Fibroblast behaviour in collagen
When porcine fibroblasts were cultivated in highly con-
centrated collagen type I hydrogels ([3 mg/ml), FdA
staining revealed that only few vital cells were present
2 days after gel preparation. Furthermore, the majority of
cells were round and did not show dendritic or stellate
morphology typical for human fibroblasts in collagen gels
and in normal dermis [40]. After prolonged cultivation in
collagen gels (10 days), some porcine fibroblasts started to
proliferate and acquired stellate morphology (data not
shown). Porcine fibroblasts seeded in fibrin gels however,
were fastly proliferating and showed dendritic or stellate
morphology already 1 day after gel preparation (data not
shown). We therefore included increasing fibrin concen-
trations from 0.2 to 1.0 mg/ml in collagen gels to stimulate
porcine fibroblasts. Confocal scanning laser microscopy of
actin-stained fibroblasts showed a clear effect of fibrin on
cell density and morphology. Already 3 days after gel
preparation, this effect was detectable and it intensified
over the ensuing days. As little as 0.2 mg/ml fibrin in
collagen increased the number of vital cells with mainly
stellate or dendritic morphology (Fig. 2a, b). This effect
was slightly more pronounced with 0.5 and 1.0 mg/ml
fibrin (Fig. 2c, d).
Porcine in vitro skin model
Already one day after seeding porcine keratinocytes on the
fibroblast-containing gels, a confluent keratinocyte layer
was established, indicating that porcine keratinocytes
can attach and survive on collagen gels (data not shown).
This keratinocyte layer was stable during the initial sub-
mersed cultivation phase. During the following air-exposed
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cultivation phase, a partly stratified epidermis developed
(Fig. 3a): a distinct basal layer, 5–7 suprabasal layers, and
a well developed stratum corneum (conjunctum and dis-
junctum) were present. Notably, a stratum granulosum and
spinosum could not be distinguished morphologically at
this stage. Also, the dermo-epidermal junction was not yet
fully established, resulting in an apparently accidental
separation of epidermis and dermis in histological sections
(cutting artefact). Fibroblasts were present within the der-
mal component (Fig. 3b). In summary, these features of the
engineered porcine skin were typical for in vitro generated
skin at early stages that will develop further after trans-
plantation [35].
Discussion
This is the first report on in vitro engineering of a pig cell-
derived skin analogue consisting of a multilayered epi-
dermis, a preformed dermo-epidermal junction, and a col-
lagen gel-based dermis-like structure containing fibroblasts
and essential extracellular matrix components. In other words,
the desirable basic graft profile is basically matched. The
following crucial aspects deserve a detailed comment.
First, and most importantly, the graft does exhibit the
most essential anatomical hallmarks of skin, although not
fully developed. For instance, the epidermis is not yet
normally stratified and differentiated. Also, the dermo-
epidermal junction is still weak in that cutting for histology
easily leads to disruption between epidermis and dermis
which is not the case in normal skin. Similarly, the dermal
compartment of the construct is, in reality, to be seen as a
competent template for the later establishment of a mature
dermis. Although abundant dermal fibroblasts, viewed as
the key effector cells of the dermis [41], are present, and
although certain crucial ECM components are part of the
template, the physiological inventory of components and
spatial arrangement of these is not yet accomplished.
Moreover, certain morphologic characteristics like rete
ridges and dermal vasculature are absent at this stage.
Obviously, skin appendages are absent.
This ‘‘set of imperfections’’ is mostly identical to what
we found when engineering small human cell-derived skin
analogues [34, 35]. Interestingly, after transplantation onto
immuno-incompetent rats, we observed maturation and
differentiation processes finally leading to a near normal
skin anatomy (apart from missing skin appendages) [34,
35]. It is, therefore, reasonable to assume that similar
mechanisms will also take place after autologous trans-
plantation of the described grafts in the pig model.
Second, since the planned transplantation of the skin
substitutes described here in a pig model is intended to be
the last preclinical evaluation, it is imperative that all
laboratory procedures (cell isolation, expansion, and or-
ganotypic culture system) should be identical or at least
very similar to our already established human cell-based
Fig. 1 Two-dimensional cell
culture of primary porcine
fibroblasts and keratinocytes.
a Phase contrast microscopy
shows typical spindle like
morphology of fibroblasts in
two-dimensional culture.
b Positive FdA labelling
indicates the viability of all
adherent fibroblasts. c The
majority of confluent porcine
primary keratinocytes display
typical epithelial cobblestone
morphology, while few cells are
significantly larger and round.
d FdA staining reveals that both,
the large and the small
keratinocytes, are vital. [scale
bars 50 lm (a ? b); 100 lm
(c ? d)]
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system [34, 35]. This is in fact the case for most aspects. In
particular, we used the identical cell isolation technique as
well as media and growth conditions as we did for our
human cell-derived experiments [34, 35]. The only initial
lack of correspondence was that porcine fibroblasts did not
develop as well in highly concentrated collagen gels as
human fibroblasts did. By addition of fibrin, however, this
problem could be solved effectively in that porcine fibro-
blasts were stimulated to behave like human fibroblasts.
This observation is interesting in two ways. It raises the
questions why porcine fibroblasts do not tolerate high
collagen concentrations and whether the already favourable
growth conditions for human fibroblasts could be further
improved by adding fibrin to the collagen matrix.
Fig. 2 Laser scanning confocal
microscopy of porcine
fibroblasts in three-dimensional
collagen gels, 7 days after
preparation. Actin cytoskeleton
staining (red) and nuclear
staining (blue). a In highly
concentrated collagen gels, only
few porcine fibroblasts survive
and most cells are round or have
few extensions. b–d By adding
increasing fibrin concentrations,
more fibroblasts are present and
the prevailing morphology is
stellate or dendritic. Fibrin
concentrations were
(b) 0.2 mg/ml, (c) 0.5 mg/ml,
(d) 1.0 mg/ml. (scale bars
50 lm, grids 20 lm)
Fig. 3 Histological evaluation of in vitro engineered porcine skin,
20 days in culture, H&E staining. a A partly stratified epidermis with
a well defined stratum corneum (sc), 5–7 suprabasal layers (sl), and a
dense stratum basale (sb) have developed on the dermal equivalent
(de). Of note, the junction between epidermis and dermis is still weak
and disrupted when preparing sections. b Fibroblasts were present
within the dermal component (gel). (scale bars 50 lm)
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In summary, this study shows that pig cell-derived skin
analogues closely approaching normal skin anatomy can be
engineered in vitro. Evidently, the next experimental step is
the development of an appropriate pig model in order to
establish a standardized transplantation procedure for fur-
ther studies.
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